Inherited Cancer Syndromes Current Clinical Management /

The advances in our understanding of genetics has exploded since the publication of the first edition of Inherited Cancer Syndromes. We’ve moved from an incomplete understanding of the human genome to the availability of over-the-counter DNA analysis kits. There is simply too much complicated, high-...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Ellis, C. Neal (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: New York, NY : Springer New York : Imprint: Springer, 2011.
Έκδοση:2.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03457nam a22005055i 4500
001 978-1-4419-6821-0
003 DE-He213
005 20151204160022.0
007 cr nn 008mamaa
008 101029s2011 xxu| s |||| 0|eng d
020 |a 9781441968210  |9 978-1-4419-6821-0 
024 7 |a 10.1007/978-1-4419-6821-0  |2 doi 
040 |d GrThAP 
050 4 |a RD1-811 
072 7 |a MNC  |2 bicssc 
072 7 |a MED085000  |2 bisacsh 
082 0 4 |a 617  |2 23 
245 1 0 |a Inherited Cancer Syndromes  |h [electronic resource] :  |b Current Clinical Management /  |c edited by C. Neal Ellis. 
250 |a 2. 
264 1 |a New York, NY :  |b Springer New York :  |b Imprint: Springer,  |c 2011. 
300 |a VIII, 204 p. 23 illus.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
520 |a The advances in our understanding of genetics has exploded since the publication of the first edition of Inherited Cancer Syndromes. We’ve moved from an incomplete understanding of the human genome to the availability of over-the-counter DNA analysis kits. There is simply too much complicated, high-level science for a busy clinician to meaningfully absorb without a filter. Inherited Cancer Syndromes is designed to bridge that gap. With this new edition, the clinical content has been expanded and clarified in order to be more tightly focused on the real-world implications of emerging therapies. The chapter authors are among the leading experts in these topics. Naturally, this book is not meant to be an exhaustive “how to” textbook or procedure-heavy monograph, but a clinically relevant overview of this dynamic and difficult aspect of cancer patient care. “ The chapters on syndromes are divided by type of cancer, and each includes discussions of risk assessment, indications for genetic testing, interpretation of test results, and integration into clinical management of risk estimates and results of genetic testing. The chapter on breast cancer also provides an insightful discussion of surrogate end-point markers. Each syndrome of susceptibility to polyposis and nonpolyposis colon cancer is described, with algorithms as to when genetic testing is indicated. Guidelines for prevention and management follow. … This book provides the knowledge base needed for most physicians to incorporate the principles of inherited susceptibility to cancer and genetic testing properly into their practices. It is highly recommended, since many physicians and health care workers have not been trained in this area, which has become an established part of clinical medicine.” Book Review, New England Journal of Medicine Volume 351:2137-2138 November 11, 2004 Number 20. 
650 0 |a Medicine. 
650 0 |a Cancer research. 
650 0 |a Human genetics. 
650 0 |a Oncology. 
650 0 |a Surgery. 
650 0 |a Surgical oncology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a General Surgery. 
650 2 4 |a Oncology. 
650 2 4 |a Surgical Oncology. 
650 2 4 |a Human Genetics. 
650 2 4 |a Cancer Research. 
700 1 |a Ellis, C. Neal.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9781441968203 
856 4 0 |u http://dx.doi.org/10.1007/978-1-4419-6821-0  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)